Old Web
English
Sign In
Acemap
>
Paper
>
PCN12 COST EFFECTIVENESS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) IN POLAND
PCN12 COST EFFECTIVENESS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) IN POLAND
2006
E. Orlewska
A. Szczesna
M. Gyldmark
Monika Szkultecka-Dębek
Keywords:
non-small cell lung cancer (NSCLC)
Intensive care medicine
Erlotinib
Medicine
Oncology
cost effectiveness
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI
[]